Paul A.  Keel net worth and biography

Paul Keel Biography and Net Worth

Director of Cooper Companies

Mr. Keel is a seasoned business leader with extensive global experience across a range of industries, geographies, and functions.

Paul is currently the CEO of Envista (NYSE: NVST), a global specialty med tech company, having joined in 2024.  Prior to Envista, he was CEO of Smiths Group (LON: SMIN), a diversified technology company and FTSE 100 constituent, from 2021 to 2024.  Before Smiths, he was at 3M for 16 years, serving in various leadership roles including Group President of 3M Consumer Business, President of 3M Medical, President of 3M Unitek, SVP of Manufacturing & Supply Chain, and SVP of Marketing, Sales & Business Development.  Paul’s career also includes roles at General Mills, General Electric, Norwest Equity Partners, and McKinsey & Company.

Paul holds a BA from Carleton College and an MBA from Harvard Business School.

What is Paul A. Keel's net worth?

The estimated net worth of Paul A. Keel is at least $250.42 thousand as of September 11th, 2026. Mr. Keel owns 4,701 shares of Cooper Companies stock worth more than $250,422 as of September 16th. This net worth approximation does not reflect any other assets that Mr. Keel may own. Learn More about Paul A. Keel's net worth.

How do I contact Paul A. Keel?

The corporate mailing address for Mr. Keel and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Paul A. Keel's contact information.

Has Paul A. Keel been buying or selling shares of Cooper Companies?

During the past quarter, Paul A. Keel has bought $249,999.18 in Cooper Companies stock. Most recently, on Friday, September 11th, Paul A. Keel bought 4,701 shares of Cooper Companies stock. The stock was acquired at an average cost of $53.18 per share, with a total value of $249,999.18. Following the completion of the transaction, the director now directly owns 4,701 shares of the company's stock, valued at $249,999.18. Learn More on Paul A. Keel's trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Paul Keel (Director), Lawrence Kurzius (Director), Jody Lindell (Director), Cynthia Lucchese (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Maria Rivas (Director), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, Cooper Companies insiders bought shares 10 times. They purchased a total of 42,715 shares worth more than $2,771,934.72. The most recent insider tranaction occured on September, 14th when Director Walter M Rosebrough Jr bought 3,000 shares worth more than $162,870.00. Insiders at Cooper Companies own 2.1% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 9/14/2026.

Paul A. Keel Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/11/2026Buy4,701$53.18$249,999.184,701View SEC Filing Icon  
See Full Table

Paul A. Keel Buying and Selling Activity at Cooper Companies

This chart shows Paul A. Keel's buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $53.27
Low: $52.97
High: $54.80

50 Day Range

MA: $70.88
Low: $53.27
High: $76.82

2 Week Range

Now: $53.27
Low: $51.01
High: $89.83

Volume

4,416,292 shs

Average Volume

3,236,123 shs

Market Capitalization

$10.13 billion

P/E Ratio

18.18

Dividend Yield

N/A

Beta

0.82